The Wellcome Trust Centre for Human Genetics CEA-Genomics Institute, Centre National de Génotypage ,
Yorktown Hgts, NY 10598, USA. 5 CEA-Genomics Institute, Centre National de Génotypage, Evry 91057, France. 6 The Wellcome Trust Centre for Human Genetics, 7 INSERM UMRS872, Centre de Recherche des Cordeliers, 15 Rue de l'école de Médecine, 11022801. ,
Predictors of coronary artery disease in the Lebanese population, Thrombosis Research, vol.117, issue.6, pp.631-637, 2006. ,
DOI : 10.1016/j.thromres.2005.05.022
Hypertension and the Pathogenesis of Atherosclerosis : Oxidative Stress and the Mediation of Arterial Inflammatory Response: A New Perspective, Hypertension, vol.25, issue.2, pp.155-161, 1995. ,
DOI : 10.1161/01.HYP.25.2.155
Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of beta-blockade, Al Mousa E, 2011. ,
??3-Adrenoceptor Stimulation on Top of ??1-Adrenoceptor Blockade, Journal of the American College of Cardiology, vol.53, issue.17, pp.1539-1542, 2009. ,
DOI : 10.1016/j.jacc.2009.01.048
Risk factors in middle age that predict early and late onset of coronary heart disease, Journal of Clinical Epidemiology, vol.42, issue.2, pp.95-104, 1989. ,
DOI : 10.1016/0895-4356(89)90082-6
Pharmacological approaches to improve endothelial repair mechanisms, Expert Review of Cardiovascular Therapy, vol.6, issue.8, pp.1071-1082, 2008. ,
DOI : 10.1586/14779072.6.8.1071
Clinical Factors and Angiographic Features Associated With Premature Coronary Artery Disease, Chest, vol.108, issue.2, pp.364-369, 1995. ,
DOI : 10.1378/chest.108.2.364
Blood pressure, stroke, and coronary heart disease, The Lancet, vol.335, issue.8693, pp.827-838, 1990. ,
DOI : 10.1016/0140-6736(90)90944-Z
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials, Integrated Blood Pressure Control, vol.2, pp.1-8, 2009. ,
DOI : 10.2147/IBPC.S5174
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, The Lancet, vol.359, issue.9311, pp.995-1003, 2002. ,
DOI : 10.1016/S0140-6736(02)08089-3
Some Factors Associated with the Development of Coronary Heart Disease???Six Years' Follow-Up Experience in the Framingham Study, American Journal of Public Health and the Nations Health, vol.49, issue.10, pp.1349-1356, 1959. ,
DOI : 10.2105/AJPH.49.10.1349
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers, Circulation: Cardiovascular Genetics, vol.2, issue.1, pp.7-15, 2009. ,
DOI : 10.1161/CIRCGENETICS.108.833392
Blood Pressure and the Progression of Carotid Atherosclerosis in Middle-Aged Men, Hypertension, vol.34, issue.1, pp.51-56, 1999. ,
DOI : 10.1161/01.HYP.34.1.51
Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, vol.360, pp.1903-1913, 2002. ,
Inflammation may be a bridge connecting hypertension and atherosclerosis, Med Hypotheses, vol.64, pp.925-929, 2005. ,
Endothelium-derived vasoactive agents, AT1 receptors and inflammation, Pharmacology & Therapeutics, vol.131, issue.2, pp.187-203, 2011. ,
DOI : 10.1016/j.pharmthera.2010.11.001
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, The Lancet, vol.335, issue.8692, pp.765-774, 1990. ,
DOI : 10.1016/0140-6736(90)90878-9
Early and late coronary deaths in the US Railroad study predicted by major coronary risk factors, European Journal of Cardiovascular Prevention & Rehabilitation, vol.82, issue.1, pp.382-388, 2004. ,
DOI : 10.1097/00149831-200410000-00004
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach, Mayo Clinic Proceedings, vol.84, issue.8, pp.741-757, 2009. ,
DOI : 10.4065/84.8.741
Correlations between prescription of anti-hypertensive medication and mortality due to stroke, BMC Cardiovascular Disorders, vol.356, issue.9227, p.15, 2012. ,
DOI : 10.1016/S0140-6736(00)02526-5
A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial, ACC Current Journal Review, vol.13, issue.2, pp.2805-2816, 2003. ,
DOI : 10.1016/j.accreview.2003.12.023
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents, JAMA, vol.289, issue.19, pp.2534-2544, 2003. ,
DOI : 10.1001/jama.289.19.2534
Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients, Vascular Health and Risk Management, vol.8, pp.473-481, 2012. ,
DOI : 10.2147/VHRM.S33305
Premature coronary heart disease and traditional risk factors-can we do better?, Int Cardiovasc Res J, vol.7, pp.46-50, 2013. ,
Comparison of psychosocial risk factors between patients who experience acute myocardial infarction before and after 40 years of age, Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, vol.39, issue.5, pp.396-402, 2011. ,
DOI : 10.5543/tkda.2011.01412
Non-communicable disease mortality rates using the verbal autopsy in a cohort of middle aged and older populations in Beirut during wartime, J Epidemiol Community Health, vol.55, pp.1983-93271, 2001. ,
Effects of calcium channel blockers on atherosclerosis: new insights, Acta Cardiol, vol.57, pp.249-255, 2002. ,
??-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials, Annals of Internal Medicine, vol.147, issue.1, pp.10-18, 2007. ,
DOI : 10.7326/0003-4819-147-1-200707030-00003
Two-marker association tests yield new disease associations for coronary artery disease and hypertension, Human Genetics, vol.34, issue.6, pp.725-733, 2011. ,
DOI : 10.1007/s00439-011-1009-6
The Effect of Age on Risk Factors for Ischemic Heart Disease, Annals of Epidemiology, vol.8, issue.7, pp.1948-1993, 1998. ,
DOI : 10.1016/S1047-2797(98)00011-8
The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population, Journal of Human Hypertension, vol.109, issue.11, pp.861-868, 2005. ,
DOI : 10.1038/sj.jhh.1001909
Do all antihypertensive drugs improve carotid intima-media thickness????A network meta-analysis of randomized controlled trials, Fundamental & Clinical Pharmacology, vol.22, issue.Suppl, pp.395-404, 2011. ,
DOI : 10.1111/j.1472-8206.2010.00832.x
Pathobiology of atherosclerosis: are there racial and ethnic differences?, Rev Cardiovasc Med, vol.5, pp.14-21, 2004. ,
Angiotensin-Converting Enzyme Inhibitors in the Treatment of Hypertension: An Update, The Journal of Clinical Hypertension, vol.28, issue.2, pp.876-882, 2007. ,
DOI : 10.1111/j.1524-6175.2007.07782.x
Parental consanguinity and family history of coronary artery disease strongly predict early stenosis, Atherosclerosis, vol.212, issue.2, pp.559-563, 2010. ,
DOI : 10.1016/j.atherosclerosis.2010.07.013
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, vol.342, pp.145-153, 2000. ,
Detecting rare variants for complex traits using family and unrelated data, Genetic Epidemiology, vol.14, issue.2, pp.171-187, 2010. ,
DOI : 10.1002/gepi.20449
Young coronary artery disease in patients undergoing percutaneous coronary intervention, Annals of Saudi Medicine, vol.33, issue.6, pp.572-578, 2013. ,
DOI : 10.5144/0256-4947.2013.572